Corline Biomedical (Sweden) Today
| CLBIO Stock | SEK 6.42 0.18 2.73% |
Performance0 of 100
| Odds Of DistressOver 67
|
Corline Biomedical is selling for under 6.42 as of the 23rd of November 2024; that is 2.73 percent decrease since the beginning of the trading day. The stock's lowest day price was 6.32. Corline Biomedical has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Corline Biomedical AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of October 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. The company was founded in 1991 and is based in Uppsala, Sweden. Corline Biomedical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 21.49 M outstanding shares. More on Corline Biomedical AB
Moving together with Corline Stock
| 0.74 | CAMX | Camurus AB | PairCorr |
| 0.9 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.83 | NANOFS | Nanoform Finland Plc | PairCorr |
Moving against Corline Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Corline Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Corline Biomedical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Corline Biomedical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Biotechnology, Healthcare (View all Sectors) |
Corline Biomedical AB (CLBIO) is traded on Stockholm Exchange in Sweden and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 203.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Corline Biomedical's market, we take the total number of its shares issued and multiply it by Corline Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Corline Biomedical operates under Healthcare sector and is part of Biotechnology industry. The entity has 21.49 M outstanding shares.
Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45.
Check Corline Biomedical Probability Of Bankruptcy
Ownership AllocationCorline Biomedical holds a total of 21.49 Million outstanding shares. Corline Biomedical AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Corline Ownership Details
Corline Biomedical Risk Profiles
Although Corline Biomedical's alpha and beta are two of the key measurements used to evaluate Corline Biomedical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.87 | |||
| Standard Deviation | 3.93 | |||
| Variance | 15.47 | |||
| Risk Adjusted Performance | (0.10) |
Corline Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Corline Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.